Royalty Pharma plc - Class A

$54.87
Market Cap 31.65B
ROE 8.5%
Gross Margin 100.0%
Debt/Equity 0.9
Current Ratio 2.7
Revenue QoQ 11.0%
EPS QoQ 0.2%
F-Score 6

About

Royal Pharma Plc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
37.66
vs median 15.30
P/B
3.14
vs median 3.49
ROE
0.09
vs median 0.21

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

RVMDONCALNYUTHRROIVBNTX
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics